Harris Todd's Form 4 filing
Tyra Biosciences, Inc. (TYRA) · filed Mar 23, 2023
- Accession no.
- 0001209191-23-020848
- Filed
- Mar 23, 2023
- Trade date
- Mar 21-23, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $307.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Harris ToddCIK 0001711463 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 21, 2023 | Common Stock | MOption exerciseAcquired | +12,393 | $2.25 | +$27,884.25 | 1,713,669 | Direct | |
| Mar 21, 2023 | Common Stock | SSaleDisposed | −12,393 | $16.00 | −$198,288 | 1,701,276 | Direct | |
| Mar 22, 2023 | Common Stock | MOption exerciseAcquired | +4,043 | $2.25 | +$9,096.75 | 1,705,319 | Direct | |
| Mar 22, 2023 | Common Stock | SSaleDisposed | −4,043 | $16.00 | −$64,688 | 1,701,276 | Direct | |
| Mar 23, 2023 | Common Stock | MOption exerciseAcquired | +2,800 | $2.25 | +$6,300 | 1,704,076 | Direct | |
| Mar 23, 2023 | Common Stock | SSaleDisposed | −2,800 | $16.00 | −$44,800 | 1,701,276 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 21, 2023 | Common Stock | MOption exerciseDisposed | −12,393 | $0.00 | $0 | 416,619 | Direct | |
| Mar 22, 2023 | Common Stock | MOption exerciseDisposed | −4,043 | $0.00 | $0 | 412,576 | Direct | |
| Mar 23, 2023 | Common Stock | MOption exerciseDisposed | −2,800 | $0.00 | $0 | 409,776 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.